Not Medicare Enrolled

Dr. Aneta Schuenemeyer, M.D.,

Optician · San Antonio, TX
Low-engagement
9480 HUEBNER RD, San Antonio, TX 78240
2106149595
In practice since 2005 (20 years)
NPI: 1790774198 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Schuenemeyer from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Schuenemeyer? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Schuenemeyer

Dr. Aneta Schuenemeyer is an optician specialist in San Antonio, TX, with 20 years of NPI registration.

Between the years covered by Open Payments, Dr. Schuenemeyer received a total of $13,637 from 42 pharmaceutical and/or device companies across 771 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Schuenemeyer is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice $13,637 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$13,637
Total received (2018-2024)
Avg $1,948/year across 7 years
Top 13% in TX for optician
42
Companies
771
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,637 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,178
2023
$2,303
2022
$1,753
2021
$1,969
2020
$1,484
2019
$2,184
2018
$1,767

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lundbeck LLC
$1,330
Takeda Pharmaceuticals U.S.A., Inc.
$1,300
Otsuka America Pharmaceutical, Inc.
$1,284
Teva Pharmaceuticals USA, Inc.
$1,265
Janssen Pharmaceuticals, Inc
$836
Neurocrine Biosciences, Inc.
$804
Almatica Pharma LLC
$595
Allergan Inc.
$551
ITI, Inc.
$477
AbbVie Inc.
$450
Vanda Pharmaceuticals Inc.
$374
Ironshore Pharmaceuticals Inc.
$373
Neos Therapeutics, LP
$334
Axsome Therapeutics, Inc.
$331
Avanir Pharmaceuticals, Inc.
$327
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$315
Supernus Pharmaceuticals, Inc.
$298
Alkermes, Inc.
$273
Corium, LLC
$269
ABBVIE INC.
$267
Bausch Health US, LLC
$251
Allergan, Inc.
$169
Shire North American Group Inc
$153
Noven Therapeutics, LLC
$137
IDORSIA PHARMACEUTICALS US INC
$126
Tris Pharma Inc
$111
Adlon Therapeutics L.P.
$103
Eisai Inc.
$91
IRONSHORE PHARMACEUTICALS INC.
$71
Merck Sharp & Dohme Corporation
$64
Vertical Pharmaceuticals, LLC
$45
Indivior Inc.
$44
EISAI INC.
$44
Noven Pharmaceuticals, Inc.
$35
JAZZ PHARMACEUTICALS INC.
$29
Merck Sharp & Dohme LLC
$22
LivaNova USA, Inc.
$20
Biogen, Inc.
$15
ACADIA Pharmaceuticals Inc
$14
Jazz Pharmaceuticals Inc.
$14
ARBOR PHARMACEUTICALS, INC.
$14
Otsuka Pharmaceutical Development & Commercialization, Inc.
$13
Top 3 companies account for 28.7% of total payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ADHANSIA XR · APLENZIN · ARISTADA · AUSTEDO · AZSTARYS · Adzenys XR-ODT · Austedo XR · Auvelity · Azstarys · BELSOMRA · BRINTELLIX · CAPLYTA · CITALOPRAM · COTEMPLA XR-ODT · Dayvigo · Dyanavel XR · FANAPT · Fanapt · GRALISE · HETLIOZ · Horizant · INGREZZA · INVEGA TRINZA · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · LOREEV XR · LYBALVI · METHYLPHENIDATE 72 · MYDAYIS · NUEDEXTA · NUPLAZID · OSMOLEX ER · PERSERIS · QELBREE · QUVIVIQ · REXULTI · SECUADO · SERTRALINE HCL · SPRAVATO · SUBLOCADE · SUBOXONE SUBLINGUAL FILM · SUNOSI · Sunosi · TRINTELLIX · Trintellix · UZEDY · VIIBRYD · VNS Therapy · VRAYLAR · VYVANSE · Vivitrol 380 mg · WELLBUTRIN · WELLBUTRIN XL · Xelstrym
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an optician specialist in San Antonio?
Compare opticians in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
194
Per 100K population
9.5
County median income
$70,571
Nearest hospital
SAN ANTONIO BEHAVIORAL HEALTHCARE HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment — Not enrolled N/A
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Schuenemeyer is an optician specialist, with low-engagement industry engagement in the top 13% of TX peers, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Schuenemeyer receive payments from pharmaceutical companies?
Yes. Dr. Schuenemeyer received a total of $13,637 from 42 companies across 771 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Schuenemeyer) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →